OBJECTIVES: To determine the prevalence of HPV and cervical neoplasia among HIV-infected women in southwestern China. METHODS: Cervical cytology, HPV detection by Hybrid Capture-2™ assay, and diagnostic colposcopy were followed by cervical biopsy if indicated. Logistic regression analysis was used to analyze associations between HPV co-infection and cervical intraepithelial neoplasia (CIN), and HIV-related clinical and laboratory parameters. RESULTS: Colposcopic-histopathologically proven CIN2+ lesions were present in 7/83 (8.4%) HIV-infected women. Nearly half (41/83, 43%) were co-infected with carcinogenic HPV genotypes. HPV co-infection was higher in women with colposcopic-histopathologically proven CIN2+ lesions than women with <CIN1 after adjusting for age (OR: 8.3, 95% CI: 0.9, 73.4). Women with CD4+ cell counts less than 350 cells/μL had higher CIN2+ prevalence after adjusting for current ART status and age (adjusted OR: 6.3, 95% CI: 1.1, 36.5). CONCLUSIONS: HIV/AIDS care and treatment programs should integrate effective cervical cancer prevention services to mitigate the risk of invasive cervical cancer among HIV-infected women in China.
OBJECTIVES: To determine the prevalence of HPV and cervical neoplasia among HIV-infectedwomen in southwestern China. METHODS: Cervical cytology, HPV detection by Hybrid Capture-2™ assay, and diagnostic colposcopy were followed by cervical biopsy if indicated. Logistic regression analysis was used to analyze associations between HPV co-infection and cervical intraepithelial neoplasia (CIN), and HIV-related clinical and laboratory parameters. RESULTS: Colposcopic-histopathologically proven CIN2+ lesions were present in 7/83 (8.4%) HIV-infectedwomen. Nearly half (41/83, 43%) were co-infected with carcinogenic HPV genotypes. HPV co-infection was higher in women with colposcopic-histopathologically proven CIN2+ lesions than women with <CIN1 after adjusting for age (OR: 8.3, 95% CI: 0.9, 73.4). Women with CD4+ cell counts less than 350 cells/μL had higher CIN2+ prevalence after adjusting for current ART status and age (adjusted OR: 6.3, 95% CI: 1.1, 36.5). CONCLUSIONS:HIV/AIDS care and treatment programs should integrate effective cervical cancer prevention services to mitigate the risk of invasive cervical cancer among HIV-infectedwomen in China.
Authors: Qinjing Pan; Jerome L Belinson; Ling Li; Robert G Pretorius; You Lin Qiao; Wen Hua Zhang; Xun Zhang; Ling Ying Wu; Sou De Rong; Yun Tian Sun Journal: Acta Cytol Date: 2003 Jan-Feb Impact factor: 2.319
Authors: V V Sahasrabuddhe; M H Mwanahamuntu; S H Vermund; W K Huh; M D Lyon; J S A Stringer; G P Parham Journal: Br J Cancer Date: 2007-04-17 Impact factor: 7.640
Authors: Vikrant V Sahasrabuddhe; Ramesh A Bhosale; Smita N Joshi; Anita N Kavatkar; Chandraprabha A Nagwanshi; Rohini S Kelkar; Cathy A Jenkins; Bryan E Shepherd; Seema Sahay; Arun R Risbud; Sten H Vermund; Sanjay M Mehendale Journal: PLoS One Date: 2010-01-08 Impact factor: 3.240
Authors: Jenell S Coleman; Michelle S Cespedes; Susan Cu-Uvin; Rose J Kosgei; May Maloba; Jean Anderson; Timothy Wilkin; Antoine Jaquet; Julia Bohlius; Kathryn Anastos; Kara Wools-Kaloustian Journal: J Low Genit Tract Dis Date: 2016-01 Impact factor: 1.925
Authors: Emmanuel Timmy Donkoh; Francis Agyemang-Yeboah; Richard Harry Asmah; Edwin K Wiredu Journal: Medicine (Baltimore) Date: 2019-03 Impact factor: 1.889
Authors: Martin Maimako Yakub; Adeola Fowotade; Chinenye Gloria Anaedobe; Mohammed Mohammed Manga; Rasheed Ajani Bakare; Bawa Ahmed Abimiku Journal: Pan Afr Med J Date: 2019-06-18
Authors: Frhana Rahmat; Jo Yee Kuan; Z Hajiman; Nik Noorul Shakira Mohamed Shakrin; Nur Aishah Che Roos; Marami Mustapa; Nur Adnin Ahmad Zaidi; Azimah Ahmad Journal: Asian Pac J Cancer Prev Date: 2021-09-01